BONEH fundamentals
An in-depth look to BBS-BIOACTIVE BONE SUBSTITUTES operating, investing, and financing activities
BONEH free cash flow for H2 23 is -1.49 M EUR. For 2023, BONEH free cash flow was -2.92 M EUR and operating cash flow was -2.92 M EUR.
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: EUR
TTM